Journal of Affective Disorders
Volume 121, Issue 1 , Pages 152-155 , February 2010

In-patient care costs of patients with bipolar I disorder: A comparison between two European centers

  • A.M. Gonzalez-Pinto

      Affiliations

    • CIBERSAM, Santiago Apóstol Hospital, Vitoria, University of the Basque Country, Spain
    • Corresponding Author InformationCorresponding author. Division of Psychiatry Research, Santiago Apostol Hospital, Olaguibel 29, 01004 Vitoria-Gasteiz, Alava, Spain. Tel.: +34 945007770; fax: +34 945 007764.
    • ,
  • R. Dardennes

      Affiliations

    • Clinique des Maladies Mentales et de l'Encéphale, Sainte-Anne Hospital, Paris, Cochin Faculty of Medicine, University Paris 5, Paris, France
    • ,
  • M. de Zélicourt

      Affiliations

    • University of Bask Country, Spain
    • ,
  • P. López

      Affiliations

    • CIBERSAM, Santiago Apóstol Hospital, Vitoria, University of the Basque Country, Spain
    • ,
  • R.G. Oliveros

      Affiliations

    • CIBERSAM, Santiago Apóstol Hospital, Vitoria, University of the Basque Country, Spain
    • ,
  • E. Vieta

      Affiliations

    • Bipolar Disorder Program, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain
    • ,
  • S. Barbeito

      Affiliations

    • CIBERSAM, Santiago Apóstol Hospital, Vitoria, University of the Basque Country, Spain
    • ,
  • E. Echevarria

      Affiliations

    • University of Bask Country, Spain
    • ,
  • F. Fagnani

      Affiliations

    • Cemka-Eval, Bourg-la-Reine, France

Received 28 January 2009 ,Revised 13 May 2009 ,Accepted 13 May 2009.

References 

  1. Bauer MS, Shea N, McBride L, Gavin C. Predictors of service utilization in veterans with bipolar disorder: a prospective study. J. Affect. Disord. 1997;44(2–3):159–168
  2. Begley CE, Annegers JF, Swann AC, Lewis C, Coan S, Schnapp WB, et al. The lifetime cost of bipolar disorder in the US. An estimate for new cases in 1998. Pharmacoeconomics. 2001;19(5 Pt 1):483–495
  3. Bowden CL, Krishnan AA. Pharmacotherapy for bipolar depression: an economic assessment. Expert Opin. Pharmacol. 2004;5(5):1101–1107
  4. Breshanan BW, Ling DCY, Neslunan CA. The risk of hospitalization for patients with bipolar disorder. Eur. Neuropsychopharmacol. 2001;11(Suppl 3):S210–S211
  5. Bryant-Comstock L, Stender M, Devercelli G. Health care utilization and costs among privately insured patients with bipolar I disorder. Bipolar Disord. 2002;4(6):398–405
  6. Das Gupta R, Guest JF. Annual cost of bipolar disorder to UK society. Br. J. Psychiatry. 2002;180:227–233
  7. de Leon J, Diaz FJ, Becoña E, Gurpegui M, Jurado D, Gonzalez-Pinto A. Exploring brief measures of nicotine dependence for epidemiological surveys. Addict. Behav. 2003;28(8):1481–1486
  8. de Zelicourt M, Dardennes R, Verdoux H, Gandhi G, Khoshnood B, Chromette E, et al. Frequency of hospitalizations and inpatient care costs of manic episodes in patients with bipolar I disorder in France. Pharmacoeconomics. 2003;21(15):1081–1090
  9. Direction des Finances, département du contrôle de gestion de l'AP-HP, comptabilité analytique de l'année 1999; Eds. Paris: Assistance Publique-Hôpitaux de Paris.
  10. Gonzalez-Pinto A, Gutierrez M, Mosquera F, Ballesteros J, López P, Ezcurra J, et al. First episode in bipolar disorder: misdiagnosis and psychotic symptoms. J. Affect. Disord. 1998;50(1):41–44
  11. Gonzalez-Pinto A, Lalaguna B, Mosquera F, Pérez de Heredia JL, Gutierrez M, Ezcurra J, et al. Use of olanzapine in dysphoric mania. J. Affect. Disord. 2001;66(2–3):247–253
  12. González-Pinto, A., van Os, J., Pérez de Heredia, J.L., Mosquera, F., Aldama, A., Lalaguna, B., Gutiérrez, M., Micó, J.A., 2003. Age-dependence of Schneiderian psychotic symptoms in bipolar patients. Schizophr. Res., 1; 61(2–3), 157–62.
  13. Keck PE, Nabulsi AN, Taylor JL, Henke CJ, Chmiel JJ, Stanton SP, et al. A pharmacoeconomic model of divalproex vs. lithium in the acute and prophylactic treatment of bipolar I disorder. J. Clin. Psychiatry. 1996;57(5):213–222
  14. Kleinman L, Lowin A, Flood E, Gandhi G, Edgell E, Revicki D. Costs of Bipolar Disorder. Pharmacoeconomics. 2003;21(9):601–622
  15. Levine J, Chengappa KN, Brar JS, Gershon S, Kupfer DJ. Illness characteristics and their association with prescription patterns for bipolar I disorder. Bipolar Disord. 2001;3(1):41–49
  16. Li J, McCombs JS, Glen L, Stimmel GL. Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program. J. Affect. Disord. 2002;71(1–3):131–139
  17. Martinez-Aran A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea JM, Salamero M, et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord. 2007;9(1–2):103–113
  18. Narrow WE, Regier DA, Rae DS, Manderscheid RW, Locke BZ. Use of services by persons with mental and addictive disorders. Findings from the National Institute of Mental Health Epidemiologic Catchment Area Program. Arch. Gen. Psychiatry. 1993;50(2):95–107
  19. Ohsfeldt RL, Lage MJ, Rajagopalan K. Medication use, service utilization, and medical costs associated with new episodes of bipolar disorder: evidence from a retrospective claims database. Prim. Care Companion Br. J. Psychiat. 2007;9(4):280–286
  20. Olié JP, Lévy E. Manic episodes: the direct cost of a three-month period following hospitalisation. Eur. Psychiatry. 2002;17(5):278–286
  21. Organisation Mondiale de la Santé . Classification Statistique Internationale des Maladies et des problèmes de santé connexes. In: Genève  editors. Dixième révision. vol. 1:OMS; 1993;p. 1335
  22. Ösby U, Tiainen A, Backlund L, Edman G, Adler M, Hällgren J, et al. Psychiatric admissions and hospitalization costs in bipolar disorder in Sweden. J. Affect. Disord. 2009;115(3):315–322
  23. Räsänan P, TiiHonen J, Hakko H. The incidence and onset-age of hospitalized bipolar affective disorder in Finland. J. Affect. Disord. 1998;48(1):63–68
  24. Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The de facto US mental and addictive disorders service systems. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch. Gen. Psychiatry. 1993;50(2):85–94
  25. Simon GE, Unützer J. Health care utilization and costs among patients treated for bipolar disorder in an insured population. Psychiatr. Serv. 1999;50(10):1303–1308
  26. Steffens DC, Krishnan KR. Decision model for the acute treatment of mania. Depress. Anxiety. 1996–1997;4(6):289–293
  27. Stender M, Bryant-Comstock L, Phillips S. Medical resource use among patients treated for bipolar disorder: a retrospective, cross-sectional, descriptive analysis. Clin. Ther. 2002;24(10):1668–1676
  28. Stensland MD, Jacobson JG, Nyhuis A. Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care. J. Affect. Disord. 2007;101(1–3):187–193
  29. Suppes T, Dennely EB, Gibbons EW. The longitudinal course of bipolar disorder. J. Clin. Psychiatry. 2000;61(Supple 9):23–30
  30. Tohen M, Calabrese J, Vieta E, Bowden C, Gonzalez-Pinto A, Lin D, et al. Effect of comorbid anxiety on treatment response in bipolar depression. J. Affect. Disord. 2007;104(1–3):137–146
  31. Winokur G, Coryell W, Keller M, Endicott J, Akiskal H. A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch. Gen. Psychiatry. 1993;50(6):457–465
  32. Wyatt RJ, Henter I. An economic evaluation of manic-depressive illness-1991. Soc. Psychiatry Psychiatr. Epidemiol. 1995;30(5):213–219

PII: S0165-0327(09)00218-3

doi: 10.1016/j.jad.2009.05.010

Journal of Affective Disorders
Volume 121, Issue 1 , Pages 152-155 , February 2010

Article Tools